Ohama H - Search Results

1

Clinical usefulness of newly developed prognostic predictive score for atezolizumab plus bevacizumab for hepatocellular carcinoma.

Ohama H, Hiraoka A, Tada T, Hirooka M, Kariyama K, Hatanaka T, Tani J, Takaguchi K, Atsukawa M, Itobayashi E, Nishimura T, Tsuji K, Tajiri K, Ishikawa T, Yasuda S, Toyoda H, Fukunishi S, Ogawa C, Kakizaki S, Shimada N, Naganuma A, Kawata K, Kosaka H, Kuroda H, Matono T, Yata Y, Ochi H, Tada F, Nouso K, Morishita A, Itokawa N, Okubo T, Arai T, Tsutsui A, Nagano T, Yokohama K, Nishikawa H, Imai M, Koizumi Y, Nakamura S, Iijima H, Kaibori M, Hiasa Y, Kumada T; Representing the Real‐life Practice Experts for HCC Study Group with Hepatocellular Carcinoma experts from 48 clinics in Japan (RELPEC/HCC 48 Group). Ohama H, et al. Cancer Rep (Hoboken). 2024 Apr;7(4):e2042. doi: 10.1002/cnr2.2042. Cancer Rep (Hoboken). 2024. PMID: 38577725 Free PMC article.

2

The third effect of polarizing electrodes and the counter current effect of electrotonus.

SUZUKI M, OHAMA H. SUZUKI M, et al. Among authors: ohama h. Jpn J Physiol. 1959 Jun 25;9(2):178-89. doi: 10.2170/jjphysiol.9.178. Jpn J Physiol. 1959. PMID: 13672690 No abstract available.

3

Splenic artery aneurysm masquerading as a pancreatic tumor--diagnosis by contrast-enhanced endoscopic ultrasound.

Ogura T, Masuda D, Kurisu Y, Ohama H, Imoto A, Takii M, Takeuchi T, Inoue T, Tokioka S, Umegaki E, Higuchi K. Ogura T, et al. Among authors: ohama h. Endoscopy. 2012;44 Suppl 2 UCTN:E428-9. doi: 10.1055/s-0032-1325861. Epub 2012 Dec 20. Endoscopy. 2012. PMID: 23258487 No abstract available.

4

Basic studies on N''-ursodeoxycholyldiethylenetriamine-N,N,N'-triacetic acid for the dissolution of calcified gallstones.

Takahashi M, Konishi T, Maeda Y, Fukuzawa M, Nishida T, Ohya T, Katayama K, Kakehi N, Sakakura H, Takagi A, Maeda M, Ohama H. Takahashi M, et al. Among authors: ohama h. Biol Pharm Bull. 1998 Jun;21(6):551-7. doi: 10.1248/bpb.21.551. Biol Pharm Bull. 1998. PMID: 9657036

5

[Plasma disappearance or serum bile acids in patients with constitutional hyperbilirubinemias and constitutional ICG excretory defect (author's transl)].

Nambu M, Namihisa T, Yamashiro Y, Ohama H, Maeda M, Ueda H. Nambu M, et al. Among authors: ohama h. Nihon Shokakibyo Gakkai Zasshi. 1980 Sep;77(9):1369-77. Nihon Shokakibyo Gakkai Zasshi. 1980. PMID: 7441913 Japanese. No abstract available.

6

[An evaluation of nutritional standards by the health examination for aged in the Okinawan community (author's transl)].

Akamatsu T, Furumi K, Fukushima T, Ohama H, Suzuki M, Noda H. Akamatsu T, et al. Among authors: ohama h. Nihon Ronen Igakkai Zasshi. 1980 Jan;17(1):39-48. doi: 10.3143/geriatrics.17.39. Nihon Ronen Igakkai Zasshi. 1980. PMID: 7373932 Free article. Japanese. No abstract available.

7

Sitagliptin can inhibit the development of hepatic steatosis in high-fructose diet-fed ob/ob mice.

Sujishi T, Fukunishi S, Ii M, Nakamura K, Yokohama K, Ohama H, Tsuchimoto Y, Asai A, Tsuda Y, Higuchi K. Sujishi T, et al. Among authors: ohama h. J Clin Biochem Nutr. 2015 Nov;57(3):244-53. doi: 10.3164/jcbn.15-84. Epub 2015 Nov 1. J Clin Biochem Nutr. 2015. PMID: 26566312 Free PMC article.

8

Co-Administration of Saireito Enabled the Withdrawal of Corticosteroids in an Elderly Woman with Autoimmune Hepatitis.

Fukunishi S, Nishida S, Nakamura K, Yokohama K, Ohama H, Asai A, Tsuda Y, Higuchi K. Fukunishi S, et al. Among authors: ohama h. Intern Med. 2016;55(1):43-7. doi: 10.2169/internalmedicine.55.5128. Epub 2016 Jan 1. Intern Med. 2016. PMID: 26726084 Free article.

9

Rosuvastatin as a potential preventive drug for the development of hepatocellular carcinoma associated with non-alcoholic fatty liver disease in mice.

Yokohama K, Fukunishi S, Ii M, Nakamura K, Ohama H, Tsuchimoto Y, Asai A, Tsuda Y, Higuchi K. Yokohama K, et al. Among authors: ohama h. Int J Mol Med. 2016 Nov;38(5):1499-1506. doi: 10.3892/ijmm.2016.2766. Epub 2016 Oct 3. Int J Mol Med. 2016. PMID: 28025996

10

A long-lasting dipeptidyl peptidase-4 inhibitor, teneligliptin, as a preventive drug for the development of hepatic steatosis in high-fructose diet-fed ob/ob mice.

Nakamura K, Fukunishi S, Yokohama K, Ohama H, Tsuchimoto Y, Asai A, Tsuda Y, Higuchi K. Nakamura K, et al. Among authors: ohama h. Int J Mol Med. 2017 Apr;39(4):969-983. doi: 10.3892/ijmm.2017.2899. Epub 2017 Feb 20. Int J Mol Med. 2017. PMID: 28260070

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

134 results

Search Page